These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8872676)

  • 1. Telemetry monitoring of pulmonary arterial pressure in freely moving rats.
    Hess P; Clozel M; Clozel JP
    J Appl Physiol (1985); 1996 Aug; 81(2):1027-32. PubMed ID: 8872676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous pulmonary and systemic blood pressure and ECG Interval measurement in conscious, freely moving rats.
    Rey M; Weber EW; Hess PD
    J Am Assoc Lab Anim Sci; 2012 Mar; 51(2):231-8. PubMed ID: 22776124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term monitoring of pulmonary arterial pressure in conscious, unrestrained mice.
    Schwenke DO; Pearson JT; Mori H; Shirai M
    J Pharmacol Toxicol Methods; 2006; 53(3):277-83. PubMed ID: 16338149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A refined radio-telemetry technique to monitor right ventricle or pulmonary artery pressures in rats: a useful tool in pulmonary hypertension research.
    Handoko ML; Schalij I; Kramer K; Sebkhi A; Postmus PE; van der Laarse WJ; Paulus WJ; Vonk-Noordegraaf A
    Pflugers Arch; 2008 Feb; 455(5):951-9. PubMed ID: 17912547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventive effects of raloxifene, a selective estrogen receptor modulator, on monocrotaline-induced pulmonary hypertension in intact and ovariectomized female rats.
    Nishida M; Hasegawa Y; Tanida I; Nakagawa E; Inaji H; Ohkita M; Matsumura Y
    Eur J Pharmacol; 2009 Jul; 614(1-3):70-6. PubMed ID: 19379725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urantide alleviates monocrotaline induced pulmonary arterial hypertension in Wistar rats.
    Mei Y; Jin H; Tian W; Wang H; Wang H; Zhao Y; Zhang Z; Meng F
    Pulm Pharmacol Ther; 2011 Aug; 24(4):386-93. PubMed ID: 21396478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The orally active nonpeptide selective endothelin ETA receptor antagonist YM598 prevents and reverses the development of pulmonary hypertension in monocrotaline-treated rats.
    Yuyama H; Fujimori A; Sanagi M; Koakutsu A; Sudoh K; Sasamata M; Miyata K
    Eur J Pharmacol; 2004 Aug; 496(1-3):129-39. PubMed ID: 15288584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fasudil reduces monocrotaline-induced pulmonary arterial hypertension: comparison with bosentan and sildenafil.
    Mouchaers KT; Schalij I; de Boer MA; Postmus PE; van Hinsbergh VW; van Nieuw Amerongen GP; Vonk Noordegraaf A; van der Laarse WJ
    Eur Respir J; 2010 Oct; 36(4):800-7. PubMed ID: 20351034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial and anti-inflammatory effects of chronic bosentan therapy in monocrotaline-induced pulmonary hypertension.
    Fontoura D; Oliveira-Pinto J; Tavares-Silva M; Leite S; Vasques-Nóvoa F; Mendes-Ferreira P; Lourenço AP; Leite-Moreira AF
    Rev Port Cardiol; 2014 Apr; 33(4):213-22. PubMed ID: 24780128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonspecific endothelin-receptor antagonist blunts monocrotaline-induced pulmonary hypertension in rats.
    Hill NS; Warburton RR; Pietras L; Klinger JR
    J Appl Physiol (1985); 1997 Oct; 83(4):1209-15. PubMed ID: 9338430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model.
    Liu CP; Dai ZK; Huang CH; Yeh JL; Wu BN; Wu JR; Chen IJ
    Kaohsiung J Med Sci; 2014 Jun; 30(6):267-78. PubMed ID: 24835346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral sildenafil prevents and reverses the development of pulmonary hypertension in monocrotaline-treated rats.
    Liu H; Liu ZY; Guan Q
    Interact Cardiovasc Thorac Surg; 2007 Oct; 6(5):608-13. PubMed ID: 17670742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRX-08066, a novel 5-hydroxytryptamine receptor 2B antagonist, reduces monocrotaline-induced pulmonary arterial hypertension and right ventricular hypertrophy in rats.
    Porvasnik SL; Germain S; Embury J; Gannon KS; Jacques V; Murray J; Byrne BJ; Shacham S; Al-Mousily F
    J Pharmacol Exp Ther; 2010 Aug; 334(2):364-72. PubMed ID: 20430844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzenesulfonamide attenuates monocrotaline-induced pulmonary arterial hypertension in a rat model.
    Zapata-Sudo G; Pontes LB; da Silva JS; Lima LM; Nunes IK; Barreiro EJ; Sudo RT
    Eur J Pharmacol; 2012 Sep; 690(1-3):176-82. PubMed ID: 22728079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling.
    Schäfer S; Ellinghaus P; Janssen W; Kramer F; Lustig K; Milting H; Kast R; Klein M
    Cardiovasc Res; 2009 Apr; 82(1):30-9. PubMed ID: 19131365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exaggerated pulmonary hypertension with monocrotaline in rats susceptible to chronic mountain sickness.
    Colice GL; Hill N; Lee YJ; Du H; Klinger J; Leiter JC; Ou LC
    J Appl Physiol (1985); 1997 Jul; 83(1):25-31. PubMed ID: 9216940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bosentan, sildenafil, and their combination in the monocrotaline model of pulmonary hypertension in rats.
    Clozel M; Hess P; Rey M; Iglarz M; Binkert C; Qiu C
    Exp Biol Med (Maywood); 2006 Jun; 231(6):967-73. PubMed ID: 16741032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosuvastatin, sildenafil and their combination in monocrotaline-induced pulmonary hypertension in rat.
    Jasińska-Stroschein M; Owczarek J; Wesołowska A; Orszulak-Michalak D
    Acta Pharm; 2014 Sep; 64(3):345-53. PubMed ID: 25296680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1.
    Wang X; Yang Y; Yang D; Tong G; Lv S; Lin X; Chen C; Dong W
    J Vasc Surg; 2016 Nov; 64(5):1468-1477. PubMed ID: 26527422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of selective and unselective endothelin-receptor antagonists on prostacyclin synthase gene expression in experimental pulmonary hypertension.
    Schroll S; Arzt M; Sebah D; Stoelcker B; Luchner A; Budweiser S; Blumberg FC; Pfeifer M
    Scand J Clin Lab Invest; 2008; 68(4):270-6. PubMed ID: 18612919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.